Portal de Periódicos da CAPES

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

2013; Elsevier BV; Volume: 14; Issue: 9 Linguagem: Inglês

10.1016/s1470-2045(13)70253-5

1474-5488

Weiva Sieh, Martin Köbel, Teri A. Longacre, David D.L. Bowtell, Anna deFazio, Marc T. Goodman, Estrid Høgdall, Suha Deen, Nicolas Wentzensen, Kirsten B. Moysich, James D. Brenton, Blaise Clarke, Usha Menon, C. Blake Gilks, Andre Kim, Jason Madore, Sián Fereday, Joshy George, Laura Galletta, Galina Lurie, Lynne R. Wilkens, Michael E. Carney, Pamela J. Thompson, Rayna K. Matsuno, Susanne K. Kjær, Allan Jensen, Claus Høgdall, Kimberly R. Kalli, Brooke L. Fridley, Gary L. Keeney, Robert A. Vierkant, Julie M. Cunningham, Louise A. Brinton, Hannah Yang, Mark E. Sherman, Montserrat García‐Closas, Jolanta Lissowska, Kunle Odunsi, Carl Morrison, Shashikant Lele, Wiam Bshara, Lara Sucheston, Mercedes Jimenez‐Liñan, Kristy Driver, Jennifer Alsop, Marie Mack, Valerie McGuire, Joseph H. Rothstein, Barry P. Rosen, Marcus Q. Bernardini, Helen Mackay, Amit M. Oza, Eva Wozniak, Elizabeth Benjamin, Aleksandra Gentry‐Maharaj, Simon A. Gayther, Anna V. Tinker, Leah Prentice, Christine Chow, Michael S. Anglesio, Sharon E. Johnatty, Georgia Chenevix‐Trench, Alice S. Whittemore, Paul D.P. Pharoah, Ellen L. Goode, David G. Huntsman, Susan J. Ramus,

Estrogen and related hormone effects

Few biomarkers of ovarian cancer prognosis have been established, partly because subtype-specific associations might be obscured in studies combining all histopathological subtypes. We examined whether tumour expression of the progesterone receptor (PR) and oestrogen receptor (ER) was associated with subtype-specific survival.